Daisuke Sugiyama

4.3k total citations · 1 hit paper
31 papers, 1.8k citations indexed

About

Daisuke Sugiyama is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Daisuke Sugiyama has authored 31 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 17 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Daisuke Sugiyama's work include Immune Cell Function and Interaction (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immunotherapy and Immune Responses (8 papers). Daisuke Sugiyama is often cited by papers focused on Immune Cell Function and Interaction (15 papers), Cancer Immunotherapy and Biomarkers (13 papers) and Immunotherapy and Immune Responses (8 papers). Daisuke Sugiyama collaborates with scholars based in Japan, United Kingdom and United States. Daisuke Sugiyama's co-authors include Hiroyoshi Nishikawa, Shimon Sakaguchi, Yuka Maeda, Ichiro Katayama, Megumi Nishioka, Atsushi Tanemura, Eiichi Sato, Yasuo Fukumori, Yuzuru Kanakura and Sachiko Ezoe and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Daisuke Sugiyama

31 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-CCR4 mAb selectively depletes effector-type FoxP3⁺CD4⁺regulatory T cells, evoking antitumor immune responses in humans

2013 505 citations Daisuke Sugiyama, Hiroyoshi Nishikawa et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Daisuke Sugiyama

Since Specialization

Citations

This map shows the geographic impact of Daisuke Sugiyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Sugiyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Sugiyama more than expected).

Fields of papers citing papers by Daisuke Sugiyama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Sugiyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Sugiyama. The network helps show where Daisuke Sugiyama may publish in the future.

Co-authorship network of co-authors of Daisuke Sugiyama

This figure shows the co-authorship network connecting the top 25 collaborators of Daisuke Sugiyama. A scholar is included among the top collaborators of Daisuke Sugiyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daisuke Sugiyama. Daisuke Sugiyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages 2025 ·JCI Insight ·Takahiko Sato, Daisuke Sugiyama, Jun Koseki, Yasuhiro Kojima, (unknown), Kazuki Sone, Hitomi Nishinakamura, Tomohiro Ishikawa, Yuichi Ishikawa, (unknown), Hitoshi Kiyoi, Hiroyoshi Nishikawa	10
2	Coactivation of innate immune suppressive cells induces acquired resistance against combined TLR agonism and PD-1 blockade 2025 ·Science Translational Medicine ·Hitomi Nishinakamura, (unknown), Takuma Irie, (unknown), Takeo Naito, (unknown), Daisuke Sugiyama, Motohiro Tamiya, Tatsuya Yoshida, Tetsunari Hase, (unknown), Kennosuke Karube, Shohei Koyama, Hiroyoshi Nishikawa	8
3	UVB Irradiation Expands Skin-Resident CD81+Foxp3+ Regulatory T Cells with a Highly Activated Phenotype 2024 ·Journal of Investigative Dermatology ·Hiroaki Shime, (unknown), (unknown), Daisuke Sugiyama, (unknown), Akimichi Morita, Sayuri Yamazaki	2
4	The HSP90 Inhibitor Pimitespib Targets Regulatory T Cells in the Tumor Microenvironment 2024 ·Cancer Immunology Research ·Ayaka Tsuge, Sho Watanabe, Akihito Kawazoe, Yosuke Togashi, Kota Itahashi, Mari Masuda, Atsuo Sai, (unknown), Hiromi Muraoka, Shuichi Ohkubo, Daisuke Sugiyama, (unknown), Shota Fukuoka, Toshihiko Doi, Kohei Shitara, Shohei Koyama, Hiroyoshi Nishikawa	6
5	Anti-tumor effects of anti-programmed cell death-1 antibody treatment are attenuated in streptozotocin-induced diabetic mice 2023 ·Scientific Reports ·Masaaki Ito, Shintaro Iwama, Daisuke Sugiyama, Yoshinori Yasuda, Takayuki Okuji, Tomoko Kobayashi, Xin Zhou, (unknown), Takeshi Onoue, Takashi Miyata, Mariko Sugiyama, Daisuke Hagiwara, Hidetaka Suga, Ryoichi Banno, Hiroyoshi Nishikawa, Hiroshi Arima	3
6	Autologous peripheral blood stem cell transplantation for Philadelphia chromosome‐positive acute lymphoblastic leukemia is safe but poses challenges for long‐term maintenance of molecular remission: Results of the Auto‐Ph17 study 2023 ·SHILAP Revista de lepidopterología ·Satoshi Nishiwaki, Isamu Sugiura, Takahiko Sato, Miki Kobayashi, (unknown), Masashi Sawa, (unknown), Motohito Okabe, Shigeki Saito, Takanobu Morishita, Akio Kohno, (unknown), Hiroatsu Iida, Shingo Kurahashi, Yachiyo Kuwatsuka, Daisuke Sugiyama, (unknown), Hiroyoshi Nishikawa, Hitoshi Kiyoi	1
7	Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade 2022 ·Life Science Alliance ·Yuki Miyai, Daisuke Sugiyama, Tetsunari Hase, Naoya Asai, Tetsuro Taki, Kazuki Nishida, Takayuki Fukui, Toyofumi F. Chen‐Yoshikawa, Hiroki Kobayashi, Shinji Mii, Yukihiro Shiraki, Yoshinori Hasegawa, Hiroyoshi Nishikawa, Yuichi Ando, Masahide Takahashi, Atsushi Enomoto	34
8	Molecular hydrogen has a positive impact on pregnancy maintenance through enhancement of mitochondrial function and immunomodulatory effects on T cells 2022 ·Life Sciences ·Chieko Aoki, Kenji Imai, (unknown), Daisuke Sugiyama, Rika Miki, Yoshihiro Koya, Tomoko Kobayashi, Takafumi Ushida, (unknown), Noriyuki Nakamura, (unknown), Hiroyoshi Nishikawa, Shinya Toyokuni, Hiroaki Kajiyama, Tomomi Kotani	4
9	Depletion of central memory CD8+ T cells might impede the antitumor therapeutic effect of Mogamulizumab 2021 ·Nature Communications ·Yuka Maeda, Hisashi Wada, Daisuke Sugiyama, Takuro Saito, Takuma Irie, Kota Itahashi, (unknown), Susumu Suzuki, Takashi Kojima, Kazuhiro Kakimi, Jun Nakajima, Takeru Funakoshi, Shinsuke Iida, Mikio Oka, Teppei Shimamura, Toshihiko Doi, Yuichiro� Doki, Eiichi Nakayama, Ryuzo Ueda, Hiroyoshi Nishikawa	29
10	Importance of lymph node immune responses in MSI-H/dMMR colorectal cancer 2021 ·JCI Insight ·(unknown), Yosuke Togashi, Shota Fukuoka, Kiwamu Akagi, Kouetsu Ogasawara, Takuma Irie, Daisuke Motooka, Yoichi Kobayashi, Daisuke Sugiyama, Motohiro Kojima, Norihiko Shiiya, Shota Nakamura, Shoichi Maruyama, Yutaka Suzuki, Masaaki Ito, Hiroyoshi Nishikawa	26
11	Flow cytometry analysis of peripheral Tregs in patients with multiple myeloma under lenalidomide maintenance 2021 ·International Journal of Hematology ·Kenji Nozaki, Yuki Fujioka, Daisuke Sugiyama, Jun Ishikawa, Masato Iida, (unknown), Satoru Kosugi, Hiroyoshi Nishikawa, Hirohiko Shibayama	1
12	Regulatory T Cell as a Biomarker of Treatment-Free Remission in Patients with Chronic Myeloid Leukemia 2021 ·Cancers ·Yuki Fujioka, Daisuke Sugiyama, Itaru Matsumura, Yosuke Minami, Masatomo Miura, Yoshiko Atsuta, Shigeki Ohtake, Hitoshi Kiyoi, Yasushi Miyazaki, Hiroyoshi Nishikawa, Naoto Takahashi	7
13	Immune Suppression by PD-L2 against Spontaneous and Treatment-Related Antitumor Immunity 2019 ·Clinical Cancer Research ·Tokiyoshi Tanegashima, Yosuke Togashi, Koichi Azuma, Akihiko Kawahara, (unknown), Daisuke Sugiyama, Fumio Kinoshita, Jun Akiba, Eiji Kashiwagi, Ario Takeuchi, Takuma Irie, Katsunori Tatsugami, Tomoaki Hoshino, Masatoshi Eto, Hiroyoshi Nishikawa	69
14	Selective inhibition of low-affinity memory CD8+ T cells by corticosteroids 2019 ·The Journal of Experimental Medicine ·(unknown), Daisuke Sugiyama, Yuka Maeda, Allison Betof Warner, Katherine S. Panageas, Sachiko Ito, Yosuke Togashi, Chika Sakai, Jedd D. Wolchok, Hiroyoshi Nishikawa	87
15	Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis 2018 ·Cancer Immunology Research ·(unknown), Hiroshi Hamana, Hiroyuki Kishi, Yoshihiro Hayakawa, Eiji Kobayashi, (unknown), (unknown), (unknown), Takuya Nagata, Daisuke Sugiyama, Hiroyoshi Nishikawa, Atsushi Tanemura, Ichiro Katayama, (unknown), Yasushi Takamatsu, Kenzaburo Tani, Tatsuhiko Ozawa, Atsushi Muraguchi	30
16	Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti–CTLA-4 antibody 2018 ·Proceedings of the National Academy of Sciences ·Danbee Ha, Atsushi Tanaka, Tatsuya Kibayashi, Atsushi Tanemura, Daisuke Sugiyama, James B. Wing, Ee Lyn Lim, Karen Wei Weng Teng, Dennis O. Adeegbe, Evan W. Newell, Ichiro Katayama, Hiroyoshi Nishikawa, Shimon Sakaguchi	153
17	Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut 2016 ·Blood ·Kazuhiko Kakihana, Yuki Fujioka, Wataru Suda, Yuho Najima, Go Kuwata, Satoshi Sasajima, Iyo Mimura, Hidetoshi Morita, Daisuke Sugiyama, Hiroyoshi Nishikawa, Masahira Hattori, Yutaro Hino, Shuntaro Ikegawa, Keita Yamamoto, Takashi Toya, Noriko Doki, Koichi Koizumi, Kenya Honda, Kazuteru Ohashi	262
18	Impact of Flushing Response on the Relationship between Alcohol Consumption and Gamma-glutamyl Transpeptidase: the KOBE study. 2016 ·PubMed ·Takumi Hirata, Aya Higashiyama, Yoshimi Kubota, Daisuke Sugiyama, Kazuyo Kuwabara, Yukako Tatsumi, Aya Hirata, Yoko Nishida, Aya Kadota, Hironori Imano, T Nishikawa, Naomi Miyamatsu, Yoshihiro Miyamoto, Tomonori Okamura	3
19	Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3 ^high regulatory T cells in humans 2015 ·Proceedings of the National Academy of Sciences ·Makoto Miyara, (unknown), Édouard Sage, Daisuke Sugiyama, Hiroyoshi Nishikawa, Diane Bouvry, Laetitia Claër, Ravi Hingorani, Robert Balderas, Jurg Rohrer, Noel L. Warner, Alain Chapelier, Dominique Valeyre, Reiji Kannagi, Shimon Sakaguchi, Zahir Amoura, Guy Gorochov	119
20	Clarifying the importance of CYP2C19 and PON1 in the mechanism of clopidogrel bioactivation and in vivo antiplatelet response 2012 ·European Heart Journal ·Inna Y. Gong, Natalie Crown, Colin Suen, Ute I. Schwarz, George K. Dresser, Michael J. Knauer, Daisuke Sugiyama, Marianne K. DeGorter, Sarah Woolsey, Rommel G. Tirona, Richard B. Kim	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact